Bionano Genomics Management
Management criteria checks 3/4
Bionano Genomics' CEO is Robert Holmlin, appointed in Jan 2011, has a tenure of 13.83 years. total yearly compensation is $1.25M, comprised of 47.7% salary and 52.3% bonuses, including company stock and options. directly owns 0.028% of the company’s shares, worth $6.31K. The average tenure of the management team and the board of directors is 3.5 years and 5.5 years respectively.
Key information
Robert Holmlin
Chief executive officer
US$1.3m
Total compensation
| CEO salary percentage | 47.7% |
| CEO tenure | 13.8yrs |
| CEO ownership | 0.03% |
| Management average tenure | 3.5yrs |
| Board average tenure | 5.5yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$136m |
| Jun 30 2024 | n/a | n/a | -US$204m |
| Mar 31 2024 | n/a | n/a | -US$227m |
| Dec 31 2023 | US$1m | US$599k | -US$232m |
| Sep 30 2023 | n/a | n/a | -US$227m |
| Jun 30 2023 | n/a | n/a | -US$147m |
| Mar 31 2023 | n/a | n/a | -US$140m |
| Dec 31 2022 | US$3m | US$544k | -US$133m |
| Sep 30 2022 | n/a | n/a | -US$117m |
| Jun 30 2022 | n/a | n/a | -US$106m |
| Mar 31 2022 | n/a | n/a | -US$92m |
| Dec 31 2021 | US$8m | US$484k | -US$72m |
| Sep 30 2021 | n/a | n/a | -US$61m |
| Jun 30 2021 | n/a | n/a | -US$51m |
| Mar 31 2021 | n/a | n/a | -US$41m |
| Dec 31 2020 | US$708k | US$376k | -US$41m |
| Sep 30 2020 | n/a | n/a | -US$37m |
| Jun 30 2020 | n/a | n/a | -US$33m |
| Mar 31 2020 | n/a | n/a | -US$32m |
| Dec 31 2019 | US$899k | US$404k | -US$30m |
| Sep 30 2019 | n/a | n/a | -US$28m |
| Jun 30 2019 | n/a | n/a | -US$27m |
| Mar 31 2019 | n/a | n/a | -US$23m |
| Dec 31 2018 | US$3m | US$390k | -US$18m |
| Sep 30 2018 | n/a | n/a | -US$18m |
| Jun 30 2018 | n/a | n/a | -US$18m |
| Mar 31 2018 | n/a | n/a | -US$22m |
| Dec 31 2017 | US$605k | US$379k | -US$23m |
Compensation vs Market: Robert's total compensation ($USD1.25M) is above average for companies of similar size in the US market ($USD649.63K).
Compensation vs Earnings: Robert's compensation has been consistent with company performance over the past year.
CEO
Robert Holmlin (56 yo)
13.8yrs
Tenure
US$1,254,658
Compensation
Dr. Robert Erik Holmlin, Ph D., M.B.A. has been the Chief Executive Officer and President of BioNano Genomics, Inc. (alternatively BioNanomatrix, Inc.) since January 12, 2011 and served as its Secretary &...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 13.8yrs | US$1.25m | 0.028% $ 6.3k | |
| Chief Operating Officer | 7yrs | US$884.78k | 0.020% $ 4.6k | |
| Chief Medical Officer | 4.3yrs | US$864.78k | 0.047% $ 10.8k | |
| VP of Accounting & Controller | 6.4yrs | no data | 0.017% $ 3.9k | |
| General Counsel & Secretary | 2.7yrs | no data | 0.019% $ 4.3k | |
| Vice President of Global Sales | 2.8yrs | no data | no data | |
| Global Head of Market Access | 2yrs | no data | no data | |
| Global Head of People Operations | 2.8yrs | no data | no data |
3.5yrs
Average Tenure
50.5yo
Average Age
Experienced Management: BNGO's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 13.8yrs | US$1.25m | 0.028% $ 6.3k | |
| Independent Director | 6.3yrs | US$72.75k | 0.0067% $ 1.5k | |
| Independent Director | 14.5yrs | US$97.75k | 0.0061% $ 1.4k | |
| Independent Chairman | 13.1yrs | US$77.75k | no data | |
| Independent Director | 4.5yrs | US$60.25k | 0.0069% $ 1.6k | |
| Independent Director | 5.5yrs | US$70.25k | no data | |
| Independent Director | 4.5yrs | US$57.75k | no data | |
| Independent Director | 2.9yrs | US$62.75k | no data | |
| Independent Director | 2.8yrs | US$57.75k | no data |
5.5yrs
Average Tenure
59yo
Average Age
Experienced Board: BNGO's board of directors are considered experienced (5.5 years average tenure).